Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer
β Scribed by G. Bea A. Wisman; Ageeth J. Knol; Marco N. Helder; Mindert Krans; Elisabeth G.E. de Vries; Harry Hollema; Steven de Jong; Ate G.J. van der Zee
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 110 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Breast cancer accounts for one-fourth of cancer cases seen in female patients in Kerala, India. Results of a retrospective analysis of breast cancer in Kerala are presented in this article. Methods. Case records of 449 patients with breast carcinoma treated during 1983-1984 were reviewe
Cell cycle deregulation can occur at different levels in cancer. In human breast cancer it includes overexpression of cyclins D1 and E, down-regulation of cyclin-dependent kinase inhibitors and inactivation of the retinoblastoma and p53 tumor suppressor proteins. Telomerase activity is strongly asso
Flow cytometry was used to study the incidence of aneuploidy and to determine the significance of multiple sampling from colorectal tumors. DNA ploidy pattern has been proposed as a supplementary prognostic marker, but discrepancies in findings are major. DNA clonal heterogeneity, defined as two or